Answers are grounded in this paper and cite their sources.
This author holds that the MetS counts as a multiplex cardiovascular risk factor that is clinically useful and will lead to advances in diagnosis and treatment of an important cause of cardiovascular disease.
No takes yet. Share an insight, caveat, or question.
Scott M. Grundy (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: